Professor Andrew Lever

Andrew is Professor of Infectious Diseases at the University of Cambridge. He brings decades of expertise and experience in the infectious disease space.

Andrew Lever is Professor of Infectious Diseases (ID) at the University of Cambridge, where he is also an honorary consultant Physician. He qualified in Wales and trained in General Medicine and ID mainly in London. He did his MD funded by the Medical Research Council (MRC) on primary immunodeficiency during which he identified the risk of transmission of hepatitis through immunoglobulin concentrates. He held a Wellcome Trust funded lectureship in ID at the Royal Free Hospital where he studied the interferon system and chronic viral infections including hepatitis B and cytomegalovirus. He moved to Harvard to work on the newly emerging virus HIV and while there identified the HIV encapsidation signal.

Since then he has been an academic clinician in London and, since 1991, Cambridge, combining clinical work with a research programme on the structural and molecular biology of viruses, focussed on HIV but including other viruses such as rotavirus and dengue. He has had continuous MRC grant support since 1989 to pursue this work. He has collaborated with GSK in development of novel antiviral agents.

He continues to do clinical research and was part of the recent RIVER trial of HIV eradication and contributed to the ‘London’ HIV cure patient. He has published widely on infectious diseases on subjects including, HIV, hepatitis, meningitis and malaria.